Company Snapshot
Founded in 2017 as a Memorial Sloan Kettering spin-out
Develops AI pathology software to transform cancer diagnosis and treatment
First FDA-cleared AI application in pathology
Built Virchow, a pioneering million-slide foundation-model for cancer
Raised ~US $239 million in venture funding
Serves >1,000 institutions across 45 countries
Estimated FY-2024 revenue of ~US $15 million
~80 staff members
Key Achievements
Paige.AI distinguishes itself by developing the first FDA-cleared AI application in pathology and by building Virchow, a pioneering million-slide foundation-model for cancer analysis.